Statement Of Cash Flows [Abstract]

STADA Arzneimittel AG - Filing #6743034

Concept 2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
As at
2019-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Profit (loss)
16,871 EUR
246,939 EUR
246,939 EUR
263,810 EUR
181,899 EUR
167,314 EUR
14,585 EUR
167,314 EUR
Adjustments to reconcile profit (loss) [abstract]
Adjustments for income tax expense
68,565 EUR
38,592 EUR
Adjustments for decrease (increase) in inventories
32,017 EUR
279,838 EUR
Adjustments for decrease (increase) in trade accounts receivable
47,190 EUR
115,095 EUR
Adjustments for increase (decrease) in trade accounts payable
34,490 EUR
51,062 EUR
Adjustments for provisions
6,777 EUR
3,551 EUR
Other adjustments for non-cash items
195,907 EUR
317,908 EUR
Adjustments for losses (gains) on disposal of non-current assets
647,000 EUR
12,054 EUR
Cash flows from (used in) operating activities
598,245 EUR
405,890 EUR
Cash flows from (used in) investing activities [abstract]
Cash flows from losing control of subsidiaries or other businesses, classified as investing activities
- EUR
0 EUR
Other cash receipts from sales of equity or debt instruments of other entities, classified as investing activities
- EUR
- EUR
Other cash payments to acquire equity or debt instruments of other entities, classified as investing activities
1,000 EUR
1,133 EUR
Proceeds from sales of property, plant and equipment, classified as investing activities
2,221 EUR
4,823 EUR
Purchase of property, plant and equipment, classified as investing activities
78,637 EUR
64,732 EUR
Proceeds from sales of intangible assets, classified as investing activities
562,000 EUR
214,000 EUR
Purchase of intangible assets, classified as investing activities
236,053 EUR
433,231 EUR
Cash flows from (used in) investing activities
307,820 EUR
1.225.343 EUR
Cash flows from (used in) financing activities [abstract]
Payments from changes in ownership interests in subsidiaries that do not result in loss of control
3,463 EUR
52,037 EUR
Proceeds from borrowings, classified as financing activities
520,969 EUR
2.237.567 EUR
Repayments of borrowings, classified as financing activities
235,032 EUR
806,753 EUR
Payments of lease liabilities, classified as financing activities
25,869 EUR
29,803 EUR
Interest paid, classified as financing activities
114,744 EUR
93,942 EUR
Cash flows from (used in) financing activities
35,314 EUR
886,509 EUR
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
255,111 EUR
67,056 EUR
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
4,430 EUR
8,845 EUR
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes
260,481 EUR
59,962 EUR
Cash and cash equivalents
526,482 EUR
266,001 EUR
206,039 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.